The U.S. Patent and Trademark Office on Tuesday invalidated another Rambus Inc. patent that has been at the center of the technology licensing firm’s victories at the U.S. International Trade Commission.
Three former Groupon Inc. sales reps the company sued for defecting to Google Inc. and allegedly stealing trade secrets filed a countercomplaint in Illinois state court Friday, alleging the online coupon company intentionally filed sham litigation and asking the court to void noncompete covenants in their Groupon contracts.
A Delaware federal judge on Friday dismissed entertainment data provider Rovi Corp.'s complaint alleging popular online video provider Hulu LLC infringed three patents related to electronic programming guides, saying the suit must contain more facts supporting the allegations in order to continue.
Allergan Inc. lodged a patent infringement suit in Texas federal court on Friday seeking to stop Hi-Tech Pharmacal Co. Inc. from launching a generic version of Allergan's glaucoma medication Lumigan.
A man who won a judgment of attorneys’ fees and costs after a judge tossed a case brought against him by copyright holding company Righthaven LLC told the Ninth Circuit on Wednesday the judgment should be upheld, arguing the district court had used its discretion properly in granting the award.
A Virginia federal judge on Friday rejected a pair of post-trial motions lodged by body armor maker Kolon Industries Inc., leaving intact a $920 million trade secrets verdict for industry rival DuPont Co.
A Massachusetts federal judge ruled Wednesday that U.S. copyright law preempted legal advertising company Market Masters-Legal's claim that personal injury firm Parker Waichman LLP had breached its contract by continuing to use ad materials from Market Masters after dropping the company.
Patent-holding company Klausner Technologies Inc. sued MetroPCS Communications Inc. in Texas federal court on Thursday, alleging the wireless carrier infringed two of its visual voice mail patents.
An Oklahoma federal jury slapped Medtronic Inc. with an almost $10 million verdict on Thursday in a suit brought by a cardiologist alleging the medical technology company infringed a patent covering a catheter design used in angioplasty.
A German court on Friday tossed Samsung Electronics Co. Ltd.’s second patent claim against Apple Inc. over mobile telecommunications technology a week after the court rejected its claim over a related patent, according to a patent expert’s blog.
Washington-based litigation firm Weisbrod Matteis & Copley PLLC has lured a former technology trade secrets prosecutor for the U.S. Department of Justice from Shulman Rogers Gandal Pordy & Ecker PA, the firm announced Monday.
The Federal Circuit on Friday tossed a $56 million infringement verdict against Ford Motor Co. after finding a lower court had failed to recognize the similarities between the automobile emergency light patent-in-suit and a French patent published nearly 40 years earlier.
A Georgia advertising agency that claims it took the photo used on the cover of erstwhile presidential candidate Herman Cain's autobiography hit Cain and publisher Simon & Schuster Inc. with a copyright suit Thursday, alleging the photo was used without permission.
An author slammed The McGraw-Hill Cos. Inc. with a proposed breach of contract class action Wednesday in New York, claiming the publisher failed to properly compensate authors for royalties on books sold for use in foreign countries.
With technology giants expected to jostle for bankrupt Eastman Kodak Co.'s enviable collection of patents, attorneys say building a strong patent portfolio is not only critical for companies wanting to protect their innovations and set themselves apart from rivals, it gives them more leverage in litigation.
The European Commission has dropped its claims that Servier SAS provided false and misleading information during an investigation, but will continue its probe of whether the French pharmaceutical company reached anti-competitive deals with generic-drug makers, the regulator said Friday.
A federal judge in Illinois on Wednesday further whittled down a sprawling patent dispute between Apple Inc. and Motorola Inc. over smartphone technology, ruling that Motorola didn't infringe two Apple patents related to replaceable network components.
A Pennsylvania federal jury on Thursday reached a verdict that Varian Medical Systems Inc. willfully infringed a University of Pittsburgh patent for a device used in radiation cancer treatments.
A Wisconsin federal judge reopened a lawsuit Thursday in which genetic research company Affymetrix Inc. seeks to add an inventor to two Illumina Inc. patents related to microarray technology, and shot down a renewed dismissal bid from Illumina.
Pharmaceutical giants AstraZeneca AB, Merck Sharp & Dohme Corp. and KBI Inc. reached a settlement Thursday with Indian drugmaker Lupin Ltd. in a patent dispute over stomach acid reflux drug Nexium.
The Seventh Circuit ruling in In re XMH Corp. is consistent with several bankruptcy court opinions following the "universal rule" that a trademark license cannot be assigned without the licensor's express consent. The decision is notable, however, as it is the first published opinion on the circuit level regarding the issue, says Joseph Tiller of Jones Day.
Recent changes to the rules for ex parte appeals to the Board of Patent Appeals from a final rejection of a patent application should make the appeal process quicker and easier on the owners and patent examiners, as well as focus the board’s attention on the substantive issues in the appeal, says Kenneth Horton of Kirton McConkie PC.
The European Patent Office's new procedures provide certainty relating to additional examination opportunities that are available when the EPO is the International Preliminary Examining Authority, which raises several strategy questions for Patent Cooperation Treaty applicants, says Stuart Schanbacher of Condo Roccia LLP.
Although the Biologics Price Competition and Innovation Act was signed into law in 2010 as part of the Patient Protection and Affordable Care Act, biosimilars law is not a settled matter. The debate between supporters and opponents is still ongoing regarding many aspects of the PPACA, and the BPCIA could be subsumed into this political battle, says Brian Dorn of Merchant & Gould PC.
Last year was the most active and productive one since the enactment of the Economic Espionage Act more than 15 years ago. The convictions obtained and significant sentences imposed in 2011 send a strong message of general and specific deterrence, say Mark Krotoski and Richard Scott of the U.S. Department of Justice.
The year 2011 was packed with art litigation that ranged from broad constitutional questions to the ever-present scourge of forgeries. Here are highlights of some of the most important cases, say Christine Steiner and Lano Williams of Sheppard Mullin Richter & Hampton LLP.
Prior to the passage of the America Invents Act, submissions of prior art by third parties were allowed in pending patent applications, but the third parties were not allowed to comment on the prior art. Preissuance submissions by third parties will create a quasi-inter partes process and result in higher quality patents, says Patrick Jewik of Kilpatrick Townsend and Stockton LLP.
While the Trademark Trial and Appeal Board's recent decision in Frito-Lay North America Inc. v. Princeton Vanguard LLC does not impose bright-line rules, it suggests that a party seeking massive and expensive e-discovery will have an uphill fight in justifying that effort and expense, say Andrew Baum and David Copland of Foley & Lardner LLP.
The tactics used to register, challenge or enforce intellectual property rights in foreign jurisdictions must be carefully viewed through the Foreign Corrupt Practices Act/Travel Act lens. We have created the IP FCPA/Travel Act decision tree, which uniquely traces out the key questions to be answered in any potential corruption case, say Douglas Sawyer and Markus Funk of Perkins Coie LLP.
The Ninth Circuit decisions in GoPets Ltd. v. Hise and Office Depot Inc. v. Zuccarini have made it easier for creditors to confidently access and auction domain names as security for loans or to satisfy judgments. However, there are trademark and administrative obstacles that continue to hinder a creditor’s clean monetization of the value in domain names, says Gavin George of Haynes and Boone LLP.